Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

ECG Cases with Traces

Dr David Yeo

Dr David Yeo

Gallbladder – When Surgery Is Or Is Not Needed

Dr Susannah Graham & Dr Sanjeev Kumar

Dr Susannah Graham & Dr Sanjeev Kumar

Panel Discussion on Adjuvant Hormone Therapy Post Breast Cancer

Dr Peter Lin

Dr Peter Lin

Covid-19 Infection – What We Know Now

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024